Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus sufentanil versus propofol plus sufentanil for anesthesia induction hemodynamics in elderly patients with hypertension undergoing lower-limb orthopedic surgery
ChiCTR2300069224Phase 4Not yet recruiting
- Sponsor
- Lishui People's Hospital
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, sufentanil and propofol in hypertension (HTN) (2 arms), sponsored by Lishui People's Hospital. Primary endpoints: hemodynamics, blood pressure and 5 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
remimazolamsufentanilpropofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2300069224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069224.